Tadaaki Nishikawa
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments 19
- Uterine Myomas and Treatments 14
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 17
- Oncology top 10%
- HER2/EGFR in Cancer Research 11
- Cancer Immunotherapy and Biomarkers 7
- Cancer Treatment and Pharmacology 7
- Cancer Cells and Metastasis 5
-
- Sarcoma Diagnosis and Treatment 19
- Co-authors
- Keiichi FujiwaraKan YonemoriDaisuke ShintaniKosei HasegawaHiroshi YoshidaTatsunori ShimoiKazuhiro TakeharaEmi Noguchi
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Tadaaki Nishikawa
65 papers receiving 708 citations
Peers
Comparison fields: 5 of 79
- Obstetrics and Gynecology 199
- Reproductive Medicine 176
- Oncology 300
- Pulmonary and Respiratory Medicine 215
- Cancer Research 94
Countries citing papers authored by Tadaaki Nishikawa
This map shows the geographic impact of Tadaaki Nishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadaaki Nishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadaaki Nishikawa more than expected).
Fields of papers citing papers by Tadaaki Nishikawa
This network shows the impact of papers produced by Tadaaki Nishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadaaki Nishikawa. The network helps show where Tadaaki Nishikawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tadaaki Nishikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 10 | |
| 13 | 2022 | 8 | |
| 14 | 2022 | 0 | |
| 15 | 2022 | 9 | |
| 16 | 2021 | 24 | |
| 17 | 2021 | 22 | |
| 18 | 2018 | 14 | |
| 19 | 2016 | 8 | |
| 20 | 2016 | 69 |
About Tadaaki Nishikawa
Tadaaki Nishikawa is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology, having authored 70 papers that have together received 717 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (19 papers), Sarcoma Diagnosis and Treatment (19 papers), Ovarian cancer diagnosis and treatment (17 papers), Uterine Myomas and Treatments (14 papers), HER2/EGFR in Cancer Research (11 papers), Cancer Immunotherapy and Biomarkers (7 papers), Cancer Treatment and Pharmacology (7 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Obstetrics and Gynecology (199 citations), Reproductive Medicine (176 citations) and Oncology (300 citations). Tadaaki Nishikawa has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Keiichi Fujiwara, Kan Yonemori, Daisuke Shintani, Kosei Hasegawa, Hiroshi Yoshida, Tatsunori Shimoi, Kazuhiro Takehara, Emi Noguchi, Kazuki Sudo and Akinobu Hamada. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.